BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
Overall, I've had a fantastic experience, one of the best companies I have worked at so far. Crossing my fingers for our success so that I can continue to work here as long as possible.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Experienced, intelligent, dedicated, and focused
Quelles sont les meilleures choses à propos de votre équipe?
I could say the same about my colleagues as I do about executive leadership.
Qu’est-ce qui vous rend le plus heureux au travail?
My manager and colleagues, the fact that I learn something new every day and will continue to learn for the foreseeable future.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Questions are encouraged, inexperience in cell therapy is acceptable, change is always welcome, people are diverse and engaged with the work, the company and the culture.
Other Employee Reviews for BlueRock Therapeutics
×